MLP Saglik Hizmetleri (MPARK) Q2 2025 earnings summary

Executive summary

• Revenue for H1 2025 grew 10.3% year-over-year to TL 24,331 million, driven by domestic private medical insurance and new hospital additions.

• EBITDA increased 8.6% year-over-year to TL 6,107 million, with margin stable at 24.7%.

• Net profit attributable to equity holders declined 5.6% year-over-year in H1 2025, reaching TL 2.49 billion, impacted by higher costs and one-off items.

• Expansion continued with six new hospitals opened in Türkiye and abroad, increasing bed capacity by 10%.

• Total assets increased to TL 65.8 billion from TL 55.2 billion as of December 31, 2024.

Financial highlights

• Q2 2025 revenue rose 14.1% year-over-year to TL 11,871 million.

• EBITDA for Q2 2025 was TL 2,897 million, up 13.1% year-over-year.

• Gross profit for H1 2025 was TL 6.48 billion, up from TL 5.63 billion year-over-year.

• Operating profit rose to TL 4.48 billion from TL 3.64 billion year-over-year.

• Cash and cash equivalents increased to TL 8.79 billion from TL 3.18 billion at year-end 2024.

Outlook and guidance

• Management expects continued revenue growth supported by domestic insurance and new hospital contributions.

• Cost management and operational efficiency remain priorities amid regulatory and wage pressures.

• Financial statements prepared in accordance with Turkish Financial Reporting Standards and inflation accounting per TAS 29.

• No events after the reporting period were noted.